It was shown that the TP53 Pro72 allele was associated with an increasing frequency of TP53 mutations in NSCLC (27), but no association was found for this polymorphism with lung cancer disease risk or prognosis. The gene discussed is TP53; the disease is non-small cell lung carcinoma.